Dow Jones industrial average index futures rose 0.3%, Standard & Poor's 500 index futures were up 0.3%. Nasdaq index futures fell 0.2%.
On Wall Street, markets hit record highs Wednesday. The S&P 500 index rose 0.8% to 1,782. The Dow gained 0.5% to 15,821.63. The Nasdaq climbed 1.2% to 3,965.58.
WEDNESDAY: Dow, S&P 500 hit new closing highs
Asian stock markets bounced higher Thursday after prepared testimony for the confirmation hearing of incoming Federal Reserve chief Janet Yellen suggested the U.S. central bank won't reduce its economic stimulus until March next year or later.
Tokyo's Nikkei 225 surged 2.1% to 14,876.41.
In Europe, most major benchmarks advanced around 1% even though official figures showed that the region's recovery from recession in the 17-country eurozone continued in the third-quarter of the year ��but only just.
Hot Japanese Companies To Invest In 2015: Active Control Techn (ACTV)
The Active Network, Inc. provides organization-based cloud computing applications services to business customers in North America, Europe, and internationally. The company offers ActiveWorks, an organization-based cloud computing platform, which transforms the way organizers record, track, manage, and share information regarding activities and events. Its ActiveWorks back-office system pulls customers� participant management, operational reporting, volunteer management, and service and payment processing functions into one hosted system. The company also provides consulting services, which consist primarily of business mapping, project management services, and guidance on best practices in using its services; and implementation services, including system set-up and configuration, and data conversion, as well as develops customized training and education programs relating to both the use and administration of its services. It serves a range of customers, including communit y and sports organizations, large corporations, small and medium-sized businesses, educational institutions, federal and state government agencies, non-profit organizations, and other related entities. The company was formerly known as Racegate.com, Inc. and changed its name to The Active Network, Inc. in May 2001. The Active Network, Inc. was founded in 1998 and is headquartered in San Diego, California.
Advisors' Opinion:- [By Luke Jacobi]
The Active Network (NYSE: ACTV) closed up 25.53 percent to $14.31 after the company agreed to be taken private by Vista Equity Partners for $1.05 billion.
- [By Rich Duprey]
Lethargic networks
As Home Depot rose in value over the past year, Active Network (NYSE: ACTV ) , an online event-management service, has been going in the opposite direction, suffering a yearlong decline that's resulted in the loss of 70% of the company's value. Yesterday, though, it went in the other direction, jumping more than 10% after announcing that it will soon be reporting its earnings. - [By Selena Maranjian]
The biggest new holdings are Liberty Media�and AbbVie. Other new holdings of interest include The Active Network (NYSE: ACTV ) , which specializes in online registrations for endurance events such as marathons and triathlons. The company recently signed a three-year deal with Ironman, and its most recent quarterly earnings report featured revenue up 12% and shrinking losses. Some have questioned the company's solvency, while others like its valuation.
Top 10 Electric Utility Stocks To Invest In Right Now: Salix Pharmaceuticals Ltd (SLXP)
Salix Pharmaceuticals, Ltd., incorporated on December 31, 2001, is a specialty pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs and medical devices used in the treatment of a variety of gastrointestinal disorders, which are those affecting the digestive tract. As of December 31, 2012, the Company�� products included XIFAXAN, MOVIPREP, APRISO, RELISTOR, OSMOPREP, SOLESTA, DEFLUX, FULYZAQ, GIAZO, METOZOLV ODT, AZASAN, ANUSOL-HC, PROCTOCORT, PEPCID, DIURIL and COLAZAL. As of December 31, 2012, its primary product candidates under development included Rifaximin, Methylnaltrexone bromide oral, Budesonide foam and Rifaximin EIR. In January 2014, Salix Pharmaceuticals, Ltd. acquired Santarus, Inc.
Xifaxan (rifaximin) tablets
Xifaxan is a gastrointestinal-specific oral antibiotic. The Food and Drug Administration ( FDA) approved Xifaxan 200 milligram for the treatment of patients 12 years of age and older with travelers��diarrhea caused by noninvasive strains of E coli. Xifaxan 550 milligram was approved by the FDA for reduction in risk of overt hepatic encephalopathy (HE), recurrence in patients 18 years of age or older.
It launched Xifaxan 200milligram in the United States and Xifaxan 550 milligram using its own direct sales force. The Company is exploring potential additional indications, formulations, clinical trials and co-promotion arrangements to capitalize on the potential for Xifaxan, including its development program in irritable bowel syndrome.
In October 2012, the USPTO declared an interference action to determine the priority of invention between Cipla�� application related to amorphous rifaximin and Solmag SpA�� application directed to amorphous rifaximin. In February 2012, the FDA posted draft bioequivalence guidance for rifaximin 550 milligram tablets. The draft guidance for rifaximin 550 milligram tablets recommends that in addition to conducting the program outlined in the FDA posted ! draft guidance document for rifaximin 200 milligram tablets discussed above, a single-dose, three-way crossover in-vivo study of fasting bioequivalence with pharmacokinetic endpoints in both fasting and fed states be performed in the 550 milligram tablets. Additionally, the guidance stipulated that the formulation of the 550 milligram strength should be proportionally similar to that of the 200 milligram strength in order to file an ANDA for approval of a generic rifaximin 550 milligram tablet for the treatment of hepatic encephalopathy.
MoviPrep (PEG 3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate and ascorbic acid) oral solution
MoviPrep is a patent-protected, liquid polyethylene glycol-salt, or PEG, bowel cleansing product that the FDA approved. MoviPrep is indicated for bowel cleansing prior to colonoscopy, intestinal surgery and barium enema X-ray examinations.
Apriso (mesalamine) extended-release capsules 0.375 gram
Apriso is a locally-acting aminosalicylate and is the only delayed and extended release mesalamine product approved by the FDA for once-a-day dosing for the maintenance of remission of ulcerative colitis. Apriso is designed to provide for the distribution of the active ingredient beginning in the small bowel and continuing throughout the colon. The product�� prolonged release mechanism might allow them to expand the range of treatment options for ulcerative colitis.
Relistor (methylnaltrexone bromide)
Relistor Subcutaneous Injection is indicated for the treatment of opioid-induced constipation (OIC) in patients with advanced illness who are receiving palliative care, when response to laxative therapy has not been sufficient. Relistor is approved for use in over 55 countries worldwide.
OsmoPrep and Visicol (sodium phosphate monobasic monohydrate, USP, sodium phosphate dibasic anhydrous, USP) tablets
Visicol and OsmoPrep tablets are indicated for clean! sing of t! he colon as a preparation for colonoscopy in adults 18 years of age or older. Visicol and OsmoPrep are the only, tablet bowel cleansing products approved by the FDA and marketed in the United States. OsmoPrep is a patented, second-generation tablet bowel cleansing product that the FDA approved. OsmoPrep offers potential benefits compared to Visico,l such as its lack of microcrystalline cellulose, smaller tablet size and possible lower dose administration.
Solesta
Solesta is a biocompatible tissue bulking agent, consisting of dextranomer microspheres and stabilized sodium hyaluronate. Solesta is indicated for the treatment of fecal incontinence in patients 18 years and older who have failed conservative therapy, such as diet, fiber therapy and/or anti-motility medications. It is the only injectable gel for this indication to be administered in an outpatient setting without the need for surgery or anesthesia.
Deflux
Deflux is a medical device indicated for children affected by Grades II-IV vesicoureteral reflux, a malformation of the urinary bladder that can result in severe infections of the kidneys and irreversible kidney damage. Deflux was granted premarket approval application (PMA) approval, and has been on the market in the United States.
Fulyzaq (crofelemer) delayed-release tablets
On December 31, 2012, the FDA granted marketing approval for this product, under the trade name Fulyzaq. Fulyzaq is indicated for the symptomatic relief of non-infectious diarrhea in adult patients with HIV/AIDS on anti-retroviral therapy. Fulyzaq should also be eligible for five years of marketing exclusivity from the date of FDA approval, and the product might be entitled to patent term restoration.
Giazo (balsalazide disodium) tablets
February 3, 2012, the FDA granted marketing approval for this product under the trade name Giazo. Giazo is indicated for the treatment of mildly to moderately active ulcerative col! itis in m! ale patients 18 years of age and older. It shipped Giazo to wholesalers in 2012.
Metozolv ODT (metoclopramide hydrochloride) 5 milligrams and 10 milligrams orally disintegrating tablets
METOZOLV ODT is indicated for the relief of symptomatic gastroesophageal reflux or short-term (4-12 weeks) therapy for adults with symptomatic, documented gastroesophageal reflux who fail to respond to conventional therapy and diabetic gastroparesis or the relief of symptoms in adults associated with acute and recurrent diabetic gastroparesis.
Azasan (azathioprine) tablets
Azasan is an FDA-approved drug that suppresses immune system responses and is indicated for preventing rejection of kidney transplants and treatment of severe arthritis. It launched the 75 and 100 milligrams dosage strengths of Azasan in the United States.
Anusol-HC and Proctocort (hydrocortisone) creams and suppositories
The Company acquired the right to sell Anusol-HC 2.5% (hydrocortisone USP) cream, Anusol-HC 25 milligrams (hydrocortisone acetate) rectal suppositories, Proctocort 1% (hydrocortisone USP) cream and Proctocort 30 mg (hydrocortisone acetate) rectal suppositories from King Pharmaceuticals, Inc. The two cream products are topical corticosteroids indicated for relief of the inflammatory and pruritic, or itching, manifestations of corticosteroid-responsive dermatoses. The two suppository products are indicated for use in inflamed hemorrhoids and postirradiation proctitis, as well as an adjunct in the treatment of chronic ulcerative colitis and other inflammatory conditions.
Pepcid (famotidine) for Oral Suspension and Diuril (Chlorothiazide)
Pepcid Oral Suspension is a widely known prescription pharmaceutical product indicated for several gastrointestinal indications, including the treatment of duodenal ulcer, benign gastric ulcer and gastro-esophageal reflux disease. Pepcid Oral Suspension and Diuril Oral Suspension, both liquid form! ulations ! of their solid dosage form counterparts, compete in a combined annual United States market concentrated in pediatric and hospitalized patient populations.
Colazal (balsalazide disodium) capsules
The Company launched Colazal to physicians in the United States. FDA approved Colazal for use in pediatric patients between 5 to 17 years of age with ulcerative colitis. The pediatric use of Colazal has been granted orphan drug designation. The Office of Generic Drugs, or OGD, approved three generic balsalazide capsule products.
The Company competes with GlaxoSmithKline plc, Giuliani S.p.A., Axcan Pharma, Inc., Abbott Laboratories, Warner Chilcott plc, Shire Pharmaceuticals Group plc, Pharmacia & Upjohn, Inc., Alaven Pharmaceutical LLC, Ferring Pharmaceuticals, Inc, Takeda Pharmaceutical Company Limited, Cumberland Pharmaceuticals, Inc, Prometheus Laboratories, Inc., Ranbaxy Pharmaceuticals, Ferndale Laboratories, GATE Pharmaceuticals , Nycomed , Medtronic, Inc., and Cubist Pharmaceuticals, Inc.
Advisors' Opinion:- [By Meg Tirrell]
Salix Pharmaceuticals Ltd. (SLXP), a maker of drugs for gastrointestinal diseases, said it will acquire Santarus Inc. (SNTS) for about $2.6 billion to gain treatments for diabetes and heartburn.
Top 10 Electric Utility Stocks To Invest In Right Now: Watsco Inc.(WSO)
Watsco, Inc., together with its subsidiaries, engages in the distribution of air conditioning, heating, and refrigeration equipment in the United States. It distributes residential central air conditioners; gas, electric, and oil furnaces; commercial air conditioning and heating equipment and systems; and other specialized equipments. The company also distributes various parts, including replacement compressors, evaporator coils, motors, and other component parts; and supplies comprising thermostats, insulation material, refrigerants, ductwork, grills, registers, sheet metal, tools, copper tubing, concrete pads, tape, adhesives, and other ancillary supplies. It serves approximately 50,000 contractors and dealers that service the replacement and new construction markets. The company also exports its products to Latin America and the Caribbean. Watsco, Inc. was founded in 1945 and is headquartered in Miami, Florida.
Advisors' Opinion:- [By Marc Bastow]
HVAC parts and components distributor Watsco (WSO) announced a 60% dividend increase to 40 cents per share, payable Oct. 31 to shareholders of record as of Oct. 10.
WSO Dividend Yield: 1.7% - [By Greg Williamson]
A successful HVAC distribution company with great growth potential
An excellent way to profit from these tailwinds is by investing in Watsco (NYSE: WSO ) (NYSE: WSO ) (NYSE: WSO ) . Watsco is a leading distributor of HVAC equipment, with more than 570 locations in the U.S., Canada, Mexico, and Puerto Rico. Watsco also exports products to Latin America and the Caribbean. - [By Michael Flannelly]
Watsco Inc (WSO), a distributor of air conditioning, heating, and refrigeration equipment, announced early on Wednesday that it is raising its quarterly dividend payout by 60%.
The company will now pay a quarterly dividend of 40 cents per share, up from the previous payout of 25 cents per share. This dividend will be paid on October 31 to shareholders of record on October 15, with an ex-dividend date of October 10.
Albert H. Nahmad, Watsco’s Chairman & Chief Executive Officer stated, “Our philosophy of sharing cash flow through dividends continues. As we have stated many times in the past, our goal over the long-term is to pay increasing dividends while maintaining a conservative balance sheet with capacity to make investments in our business and build our network. We will consider future increases in light of such investment opportunities, cash flow, general economic conditions and our overall financial condition.��/p>
Watsco shares were inactive during pre-market trading on Wednesday. The stock is up 25.49% year-to-date.
Top 10 Electric Utility Stocks To Invest In Right Now: First Trust NASDAQ Clean Edge Green Energy Index Fund (QCLN)
First Trust NASDAQ Clean Edge US (ETF) seeks investment results that correspond to the price and yield of an equity index of the NASDAQ Clean Edge U.S. Liquid Series Index. It is a market capitalization weighted index designed to track the performance of clean energy companies that are publicly traded in the United States and includes companies engaged in manufacturing, development, distribution and installation of emerging clean-energy technologies, including solar photovoltaics, biofuels and advanced batteries.
The NASDAQ Clean Edge U.S. Liquid Series Index is a modified market cap weighted index in which larger companies receive a larger index weighting. First Trust Advisors L.P. is the adviser of the fund.
Advisors' Opinion:- [By Todd Shriber, ETF Professor]
The news was predictably good for a pair of ETFs that should be known as "Tesla ETFs." The Market Vectors Global Alternatve Energy ETF (NYSE: GEX) and the First Trust NASDAQ Clean Edge Green Energy Index Fund (NASDAQ: QCLN) both traded higher on a down day for U.S. stocks, rising to within pennies of their previous 52-week highs.
Top 10 Electric Utility Stocks To Invest In Right Now: Capex SA (CAPX)
Capex SA is an Argentina-based company primarily engaged in the energy sector. The Company�� main activities include the generation and sale of electric energy; the exploration and exploitation of oil and gas, and the production, distribution and marketing of propane, butane and gasoline. The Company operates a liquefied petroleum gas (LPG) plant which is located in the province of Neuquen. As of December 31, 2011, the Company owned such subsidiaries as Hychico SA and Servicios Buproneu SA. Advisors' Opinion:- [By Dividends4Life]
Fair Value: In calculating fair value, I consider the NPV MMA Differential Fair Value along with these four calculations of fair value, see page 2 of the linked PDF for a detailed description: 1. Avg. High Yield Price 2. 20-Year DCF Price 3. Avg. P/E Price 4. Graham Number CVX is trading at a discount to only 3.) above. The stock is trading at a 44.9% premium to its calculated fair value of $82.00. CVX did not earn any Stars in this section. Dividend Analytical Data: In this section there are three possible Stars and three key metrics, see page 2 of the linked PDF for a detailed description: 1. Free Cash Flow Payout 2. Debt To Total Capital 3. Key Metrics 4. Dividend Growth Rate 5. Years of Div. Growth 6. Rolling 4-yr Div. > 15% CVX earned two Stars in this section for 2.) and 3.) above. The stock earned a Star as a result of its most recent Debt to Total Capital being less than 45%. CVX earned a Star for having an acceptable score in at least two of the four Key Metrics measured. The company has paid a cash dividend to shareholders every year since 1912 and has increased its dividend payments for 27 consecutive years. Dividend Income vs. MMA: Why would you assume the equity risk and invest in a dividend stock if you could earn a better return in a much less risky money market account (MMA) or Treasury bond? This section compares the earning ability of this stock with a high yield MMA. Two items are considered in this section, see page 2 of the linked PDF for a detailed description: 1. NPV MMA Diff. 2. Years to > MMA The NPV MMA Diff. of the $256 is below the $800 target I look for in a stock that has increased dividends as long as CVX has. The stock's current yield of 3.37% exceeds the 3.31% estimated 20-year average MMA rate. Memberships and Peers: CVX is a member of the S&P 500, a Dividend Aristocrat, a member of the Broad Dividend Achievers��Index and a Dividend Champion. The company's peer group includes: BP plc (BP) with a 4.7% yield, Exxon Mobil
Top 10 Electric Utility Stocks To Invest In Right Now: Ingles Markets Incorporated(IMKTA)
Ingles Markets, Incorporated operates a supermarket chain in the southeast United States. Its supermarkets offer food products, including grocery, meat and dairy products, produce, frozen foods, and other perishables; and non-food products, such as fuel, pharmacy products, health and beauty care products, and general merchandise, as well as provides private label items. The company?s stores also offer products and services, such as home meal replacement items, delicatessens, bakeries, floral departments, video rental departments, and greeting cards, as well as a selection of organic, beverage, and health-related items. In addition, it engages in the fluid dairy processing and shopping center rental businesses. The company operates 203 supermarkets, including 74 in Georgia, 69 in North Carolina, 36 in South Carolina, 21 in Tennessee, 2 in Virginia, and 1 in Alabama. As of September 24, 2011, it operated 74 in-store pharmacies and 70 fuel centers; owned and operated 70 shop ping centers of which 58 contain an Ingles supermarket; and owned 94 additional properties that contain a free-standing Ingles store; and owned 13 undeveloped sites. The company was founded in 1963 and is headquartered in Black Mountain, North Carolina.
Advisors' Opinion:- [By Dan Caplinger]
Ingles Markets (NASDAQ: IMKTA ) will release its quarterly report on Monday, and investors have been pleased to see shares of the regional grocery-store chain rise to levels not seen since before the financial crisis. Yet from its vantage in the Southeastern U.S., Ingles Markets has to be concerned about the impact that Kroger's (NYSE: KR ) proposed buyout of Harris Teeter (NYSE: HTSI ) might have on the competitive landscape in the region, with a potential threat to Ingles' future prospects looming over the company's stock.
Top 10 Electric Utility Stocks To Invest In Right Now: New Western Energy Corp (NWTR)
New Western Energy Corporation, incorporated on September 25, 2008, is an oil and gas and mineral exploration and production company with current projects located in Oklahoma, Kansas and Texas. The Company�� principal business is in the acquisition, exploration and development of, and production from oil, gas and mineral properties. The Company�� project includes Oklahoma Project, Texas Project, Kansas Project and Pennsylvania project. As of December 31, 2011, the Company�� total estimated unproved reserves were approximately 1,495,757 barrels of oil reserves. On January 2, 2012, the Company acquired of 100% interest in Royal Texan.
Oklahoma Project
This project comprises of two leases Glass and Phillips. The Glass Lease is located in Roger County, Oklahoma. The Glass leasehold property contains approximately 120 acres. The Phillips Lease is located in Rogers County, Oklahoma. The Phillips leasehold property contains approximately 150 acres. The Company�� oil leases located in Oklahoma were originally obtained from one lessor RC Oil Co.
Texas Project
This project comprises of three leases Swenson, Reves and McLellan. On January 27, 2011, the Company�� subsidiary New Western Texas acquired a 50% working interest in 160 acres of oil and gas leases in Jones County, Texas, known as the Swenson Lease. On August 8, 2011, the Company�� subsidiary New Western Texas was assigned from a third party a Paid Up Oil and Gas Lease agreement with Michael L. McLellan and Paula McLellan (Lessors), which provided us a 50% working interest in approximately 160 acres of land for the purpose of exploring for developing, producing and marketing oil and gas, along with all hydrocarbon and non-hydrocarbon substances produced.
Kansas Project
On December 20, 2011, entered into an assignment of oil and gas lease with an independent third party for an oil and gas property in Kansas referred to as Chautauqua Lease, whereby the assignor gra! nted the rights to the Company to carry on geographical and other exploratory work, including core drilling, and the drilling, and operating for producing, and marketing all of the oil, gas, including all associated hydrocarbons. As of December 31, 2011, the Company has not started any oil and gas exploration on Chautauqua Lease.
Pennsylvania project
The property is approximately 23 acres and is located on a glacial aged kame terrace. The terrace sands, gravels and finer sediments were deposited in response to blockage by glacial ice. Pennsylvania's Marcellus Shale natural gas producers operate approximately 50,000 wells and deliver more than 158 billion cubic feet of natural gas.
Advisors' Opinion:- [By Peter Graham] New Western Energy Corp (OTCMKTS: NWTR) May Have Enough Cash for Now
Small cap New Western Energy Corp is an independent energy company engaged in the acquisition, development, production, and exploration of oil, gas and minerals primarily in North America. On Friday, New Western Energy Corp fell 16% to $0.189 for a market cap of $13.02 million plus NWTR is down 37% over the past year and down 10% since February 2012 according to Google Finance.
No comments:
Post a Comment